Newsroom

This page contains up-to-date information on the global intellectual property proceedings relating to CRISPR-Cas9 gene editing, as well as relevant press coverage and answers to frequently asked questions.

US Legal Events

U.S. Patent and Trademark Office issues 9th and 10th CRISPR patents to CVC July 23, 2019

July 23, 2019
Read more Arrow right

U.S. Patent and Trademark Office issues 8th CRISPR patent to CVC July 16, 2019

July 16, 2019
Read more Arrow right

U.S. Patent and Trademark Office issues 7th CRISPR patent to CVC July 2, 2019

July 2, 2019
Read more Arrow right
View allArrow-right

FAQ

We answer some commonly asked questions on the CRISPR-Cas9 intellectual property situation globally.

Learn more Arrow-right

International Patent Landscape

“Europe: Legal issues lead to invalidation of 4th Broad EP patent”

May 17, 2019
Read more Arrow right

European Patent Office (EPO) awarded the Doudna-Charpentier team a broad CRISPR-Cas9 patent (EP Patent No. 3 401 400)

April 3, 2019
Read more Arrow right

“Europe: Legal issues lead to invalidation of second Broad patent; significant reduction in scope of third Broad patent”

February 15, 2019
Read more Arrow right
View allArrow-right

Press

Emmanuelle Charpentier and Jennifer A. Doudna among the 2018 Kavli Award winners

June 11, 2018
Read more Arrow right

Broad Institute takes a hit in European CRISPR patent struggle

January 18, 2018
Read more Arrow right

China Sides with Emmanuelle Charpentier and Jennifer Doudna in CRISPR Patent War

June 19, 2017
Read more Arrow right
View allArrow-right